Biotech company Alkemist Bio receives an investment of 6.9 million euros for the development of the first cell therapy w...
Neurological diseases: between research, immunotherapy with Cart-T and transfer technology
The Besta Neurological Institute and the Polytechnic of Milan will bring together different labs to work on neurological...
Treating autoimmune disorders with PIM Kinase, a unique approach
Mysthera Therapeutics AG use PIM kinase treating patients suffering with complex autoimmune disorders and Forty51 Ventur...
Verona (Human Technopole): innovation comes from a collaborative culture
“Innovation in the new millennium arises from a collaborative culture because it requires the rapid transformation of ...
Y-Doc wins the second edition of the Synlab Group Hackathon
Y-Doc is an artificial intelligence designed to assist chronic patients and caregivers in ensuring they do not forget to...
Abrignani (INGM): “Recruiting business developers to bring science to the market”
It is necessary to recruit business developers experienced in scouting academic inventions that bring “science to ...